StockClub
PERCFPercheron Therapeutics Limited$ --
Percheron Therapeutics Limited

Percheron Therapeutics Limited

PERCF

$ -

-

Review operating, investing, and financing cash flow trends alongside detailed breakdowns.

account_balanceCash Flow (CF) Summary

No cash flow data available

Cash Flow Trend (5 Years)

Investing CF
Operating CF
Financing CF
14M0
2021
2022
2023
2024
14M
2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF
Investing CF
210-1-2
20212022202320242025

waterfall_chartCash Flow Bridge (FY2025 Full Year)

Beginning / Ending
Increase
Decrease
30M20M10M0-10M
11.9M
Beginning Cash
0
Operating CF
0
Investing CF
14M
Financing CF
-15.7M
Other
10.2M
Ending Cash

Cash Flow Details

Item
2021
2022
2023
2024
2025
Net Income from Continuing Operations
Depreciation and Amortization
Stock-based Compensation
Other Non-cash Items
Adjustments to Net Income
Other Operating Activity
Change in Working Capital
Change in Account Receivables
Change in Trade Receivables
Change in Inventory
Change in Payables and Accrued Expenses
Other Working Capital Changes
Cash Flow from Operating Activities
-14.92M
-
-
-
-
-
-
-
-
-
-
-
-
Net Fixed Asset Activity
Net Investment Securities Activity
Other Investing Activity
Cash Flow from Investing Activities
7,240
-7,240
-
-
Net Borrowings
Net Issuance / Repurchase of Stock
Issuance of Capital Stock
Total Dividends Paid
Treasury / Other Financing Activity
Cash Flow from Financing Activities
-
-864,690
14.87M
-
-
13.95M
Beginning Cash and Cash Equivalents
Net Change in Cash and Cash Equivalents
Net Change in Cash and Cash Equivalents
Exchange Rate Changes
Ending Cash and Cash Equivalents
Free Cash Flow
11.87M
-1.70M
-
-
10.17M
-15.65M

Unlock Long-Term Cash Flow Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.